Related Experiment Videos
An Improved Strategy for the Chemical Synthesis of 3',5'-Cyclic Diguanylic Acid
Andrzej Grajkowski1, Mayumi Takahashi1, Tomasz Kaczyński1
1Laboratory of Biological Chemistry, Food and Drug Administration, Silver Spring, Maryland.
Current Protocols in Nucleic Acid Chemistry
|April 11, 2019
Summary
Researchers developed an improved chemical synthesis for cyclic di-GMP (c-di-GMP), a key bacterial second messenger with immune-stimulating properties. This new phosphoramidite method offers a more efficient way to produce this important molecule for potential therapeutic applications.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Cyclic di-GMP (c-di-GMP) is a crucial bacterial second messenger involved in numerous cellular processes.
- Beyond its role in bacteria, c-di-GMP acts as an immunostimulatory molecule in mammals, influencing innate and adaptive immunity.
- The broad biological significance and potential therapeutic applications of c-di-GMP necessitate efficient synthetic methods.
Purpose of the Study:
- To report an improved phosphoramidite-based chemical synthesis of c-di-GMP.
- To enhance the yield and efficiency of c-di-GMP production.
- To provide a reliable method for obtaining pure c-di-GMP for further research and drug development.
Main Methods:
- Utilized a phosphoramidite approach for c-di-GMP synthesis.
- Employed a 5'-O-formyl protecting group for efficient intermediate manipulation.
- Performed rapid and chemoselective cleavage of the protecting group to facilitate cyclocondensation.
Main Results:
- Achieved a yield of approximately 80% for the fully protected c-di-GMP intermediate.
- Obtained native c-di-GMP in an overall yield of 36% from the starting ribonucleoside after deprotection.
- Demonstrated an improved and efficient synthetic route for c-di-GMP.
Conclusions:
- The developed phosphoramidite method represents a significant advancement in the chemical synthesis of c-di-GMP.
- This improved synthesis provides a practical and high-yielding route to access c-di-GMP.
- The availability of efficiently synthesized c-di-GMP supports its further investigation as a potential nucleic-acid-based therapeutic agent.